Simultaneous triple primary malignancies, including bladder cancer, lymphoma, and lung cancer, in an elderly male: A case report-Reference-Cited by-全球学者库

Simultaneous triple primary malignancies, including bladder cancer, lymphoma, and lung cancer, in an elderly male: A case report

Published:2022-01-01 Issue:1 Volume:17 Page:1263-1268
ISSN:2391-5412
Container-title:Open Life Sciences
language:en
Short-container-title:

Author:

Huang Risheng¹,Li Zhijia²,Weng Shanshan³,Wu Shenghao³

Affiliation:

1. Department of Thoracic Surgery, The Dingli Clinical College of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University, Wenzhou Central Hospital) , Wenzhou City , Zhejiang Province , China

2. Department of Urology Surgery, The Dingli Clinical College of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University, Wenzhou Central Hospital) , Wenzhou City , Zhejiang Province , China

3. Department of Hematology, The Dingli Clinical College of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University Wenzhou Central Hospital) , Wenzhou City , Zhejiang Province , China

Abstract

Abstract Multiple primary malignancies (MPMs) are defined as the coexistence of at least two unrelated primary malignancies in a single patient, with the tumors differing in their histology. MPMs in the same patient, when present within 6 months of the primary tumor diagnosis, are considered a synchronous occurrence. In this case report, we describe a 61-year-old man who presented with three distinct tumors concurrently in 2021: noninvasive urothelial carcinoma of the bladder, diffuse large B-cell lymphoma, and squamous cell carcinoma of the lung. We discuss the process of therapy and briefly review the literature. MPMs are increasing in incidence, requiring an interdisciplinary approach to diagnosis and treatment.

Publisher

Walter de Gruyter GmbH

Subject

General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://www.degruyter.com/document/doi/10.1515/biol-2022-0500/pdf

Reference14 articles.

1. Skelton WPT, Ali A, Skelton MN, Federico R, Bosse R, Nguyen T-C, et al. Analysis of overall survival in patients with multiple primary malignancies: A single-center experience. Cureus. 2019;11(4):e4552.

2. Williamson CW, Paravati A, Ghassemi M, Lethert K, Hua P, Hartman P, et al. Five simultaneous primary tumors in a single patient: A case report and review of the literature. Case Rep Oncol. 2015;8(3):432–8.

3. Ochiai K, Kawai K, Nozawa H, Sasaki K, Kaneko M, Murono K, et al. Prognostic impact and clinicopathological features of multiple colorectal cancers and extracolorectal malignancies: A nationwide retrospective study. Digestion. 2021;102(6):911–20.

4. Minas TZ, Kiely M, Ajao A, Ambs S. An overview of cancer health disparities: new approaches and insights and why they matter. Carcinogenesis. 2021;42(1):2–13.

5. Liu Y, Zhou Y-P, Zhang M, Li L, Liao H, Ma L, et al. Clinicopathologic characteristics and outcomes of simultaneous multiple primary lung cancer. J Oncol. 2021;77(12):222–31.